Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose: Our goal is to define the contribution of genetic factors to SS and related subphenotypes.
Methods: We studied 2,459 participants in the Sjögren’s International Collaborative Clinical Alliance (SICCA) who were characterized for the Illumina HumanOmni 2.5-Quad marker set. SICCA participants were enrolled according to standardized protocols at 9 international sites, including Argentina (n=342), China (n=290), Denmark (n=446), India (n=65), Japan (n=354), the UK (n=203) and the US (total n=759 from 3 sites). Additional control data genotyped on the same platform were obtained from the Collaborative Genetic Study of Nicotine Dependence (COGEND, n = 1466). QC measures included filters based on SNP and sample missingness (≥2%), unexpected relatedness, non-Mendelian inheritance, and chromosomal regions of anomaly (> 10Mb). SICCA participants were classified according to ACR classification criteria for SS (AC&R 2012, 64; 475), including presence of focal lymphocytic sialadenitis (FLS) on minor salivary gland biopsy, presence of KCS based on ocular staining pattern (ocular staining score ≥3), and production of autoantibodies (SSA, SSB, ANA and RF). Principal components (PC) analysis was used to characterize each participant for genetic ancestry, and PCs 1 – 5 were included as covariates in all association analyses. The following phenotypes were examined: SS susceptibility (fulfillment of ACR criteria versus controls, including COGEND), presence of FLS, presence of KCS and autoantibody positive disease.
Results: Out of 2118 subjects with post-QC genotypes and sufficient clinical data, 1000 (47%) met ACR criteria for SS, and an additional 772 fulfilled at least 1 of the 3 criteria, including FLS, KCS or autoantibody positivity (SSA &/or SSB +, or both ANA ≥ 320 and RF +). A total of 1,445,406 SNPs passed all QC filters and were fully analyzed. For case-control analysis, 1,392,831 SNPs passed QC filters for both cohorts and were analyzed. Multiple variants within the MHC region on chr 6q and the IRF5-TNP03 region on chr 7 were strongly associated with SS susceptibility (lowest p values 1.9e-27 and 3.8e-13, respectively), and with autoantibody production (MHC p=1.7e-30, IRF5 p=3.2e-12) and FLS (MHC p=9.7e-12, IRF5 p=1.5e-10) within SICCA subjects; furthermore the region of MHC association for autoantibody production was much broader (26-33Mb versus 30-33Mb). In contrast, we did not observe significant genetic associations with KCS, indicating genetic heterogeneity specifically related to the oral, ocular or systemic manifestations of SS. Among SICCA subjects, multiple PCs were strongly associated with some phenotypes examined, suggesting heterogeneity according to genetic ancestry. In particular, a PC separating Asian and European ancestry was strongly associated with autoantibody production (p < 4.5e-38).
Conclusion: These results demonstrate genetic overlap of SS with other autoimmune diseases, and highlight the genetic heterogeneity of the disease according to specific subphenotypes and ancestry. Future work including imputed genetic data and additional study subjects will provide more power for extending these findings and fully characterizing the genetic contribution to SS.
Disclosure:
L. A. Criswell,
None;
K. E. Taylor,
None;
C. McHugh,
None;
C. Laurie,
None;
K. Doheny,
None;
M. Y. Lam,
None;
J. Nititham,
None;
L. Bierut,
None;
E. L. Harris,
None;
A. N. Baer,
Merck Serono,
5,
Cellgene,
5;
S. Challacombe,
None;
Y. Dong,
None;
H. Lanfranchi,
None;
M. Schiodt,
None;
M. Srinivasan,
None;
S. Sugai,
None;
H. Umehara,
None;
F. B. Vivino,
None;
Z. Yan,
None;
S. Shiboski,
None;
T. Daniels,
None;
J. S. Greenspan,
None;
C. Shiboski,
None;
« Back to 2012 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-association-analysis-reveals-genetic-heterogeneity-of-sjogrens-syndrome-ss-according-to-specific-subphenotypes-and-ancestry/